Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camilla Matassini

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Bioconjugate Chemistry|December 19, 2024
Multivalent GCase Enhancers: Synthesis and Evaluation of Glyco-Gold Nanoparticles Decorated with Trihydroxypiperidine IminosugarsFrancesca Buco, Francesca Clemente, Amelia Morrone, et al.
Bioorganic Chemistry|April 1, 2019
Dual targeting of PTP1B and glucosidases with new bifunctional iminosugar inhibitors to address type 2 diabetesXhenti Ferhati, Camilla Matassini, Maria Giulia Fabbrini, et al.
European Journal of Medicinal Chemistry|April 2, 2025
Acetal functionalized iminosugars for targeting β-glucocerebrosidase modulationMaria Giulia Davighi, Francesca Clemente, Camilla Matassini, et al.
The Journal of Organic Chemistry|September 1, 2021
Piperidine Azasugars Bearing Lipophilic Chains: Stereoselective Synthesis and Biological Activity as Inhibitors of Glucocerebrosidase (GCase)Francesca Clemente, Camilla Matassini, Sara Giachetti, et al.
European Journal of Medicinal Chemistry|June 2, 2026
Multivalent C2-alkyl trihydroxypiperidine architectures modulate β-glucocerebrosidase activityFrancesca Buco, Francesca Clemente, Francesca Cardona, et al.
Molecules (Basel, Switzerland)|July 9, 2022
Synthesis of a New β-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 GangliosidosisFrancesca Clemente, Macarena Martínez-Bailén, Camilla Matassini, et al.
Organic & Biomolecular Chemistry|February 2, 2022
Photoswitchable inhibitors of human β-glucocerebrosidaseMaria Giulia Davighi, Francesca Clemente, Camilla Matassini, et al.
Bioorganic Chemistry|August 20, 2025
Studies on Azasugar-based sulfonamides: a new class of Carbonic Anhydrase inhibitorsDebora Pratesi, Francesco Brenzini Biagioni, Camilla Matassini, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 4, 2023
Light-Triggered Control of Glucocerebrosidase Inhibitors: Towards Photoswitchable Pharmacological ChaperonesFrancesca Clemente, Maria Giulia Davighi, Camilla Matassini, et al.
Molecules (Basel, Switzerland)|January 23, 2024
Identification of GM1-Ganglioside Secondary Accumulation in Fibroblasts from Neuropathic Gaucher Patients and Effect of a Trivalent Trihydroxypiperidine Iminosugar Compound on Its Storage ReductionCostanza Ceni, Francesca Clemente, Francesca Mangiavacchi, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Bioconjugate Chemistry|December 19, 2024
Multivalent GCase Enhancers: Synthesis and Evaluation of Glyco-Gold Nanoparticles Decorated with Trihydroxypiperidine IminosugarsFrancesca Buco, Francesca Clemente, Amelia Morrone, et al.
Bioorganic Chemistry|April 1, 2019
Dual targeting of PTP1B and glucosidases with new bifunctional iminosugar inhibitors to address type 2 diabetesXhenti Ferhati, Camilla Matassini, Maria Giulia Fabbrini, et al.
European Journal of Medicinal Chemistry|April 2, 2025
Acetal functionalized iminosugars for targeting β-glucocerebrosidase modulationMaria Giulia Davighi, Francesca Clemente, Camilla Matassini, et al.
The Journal of Organic Chemistry|September 1, 2021
Piperidine Azasugars Bearing Lipophilic Chains: Stereoselective Synthesis and Biological Activity as Inhibitors of Glucocerebrosidase (GCase)Francesca Clemente, Camilla Matassini, Sara Giachetti, et al.
European Journal of Medicinal Chemistry|June 2, 2026
Multivalent C2-alkyl trihydroxypiperidine architectures modulate β-glucocerebrosidase activityFrancesca Buco, Francesca Clemente, Francesca Cardona, et al.
Molecules (Basel, Switzerland)|July 9, 2022
Synthesis of a New β-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 GangliosidosisFrancesca Clemente, Macarena Martínez-Bailén, Camilla Matassini, et al.
Organic & Biomolecular Chemistry|February 2, 2022
Photoswitchable inhibitors of human β-glucocerebrosidaseMaria Giulia Davighi, Francesca Clemente, Camilla Matassini, et al.
Bioorganic Chemistry|August 20, 2025
Studies on Azasugar-based sulfonamides: a new class of Carbonic Anhydrase inhibitorsDebora Pratesi, Francesco Brenzini Biagioni, Camilla Matassini, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 4, 2023
Light-Triggered Control of Glucocerebrosidase Inhibitors: Towards Photoswitchable Pharmacological ChaperonesFrancesca Clemente, Maria Giulia Davighi, Camilla Matassini, et al.
Molecules (Basel, Switzerland)|January 23, 2024
Identification of GM1-Ganglioside Secondary Accumulation in Fibroblasts from Neuropathic Gaucher Patients and Effect of a Trivalent Trihydroxypiperidine Iminosugar Compound on Its Storage ReductionCostanza Ceni, Francesca Clemente, Francesca Mangiavacchi, et al.
Pageof 5